ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RZLT Rezolute Inc

3.65
0.09 (2.53%)
May 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Rezolute Inc RZLT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.09 2.53% 3.65 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.62 3.40 3.72 3.69 3.56
more quote information »

Recent News

Date Time Source Heading
5/28/202414:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/24/202414:37EDGAR2Form 8-K - Current report
5/21/202416:05GLOBERezolute Reports Positive Topline Results from Phase 2 Proof..
5/17/202416:21EDGAR2Form 8-K - Current report
5/15/202416:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/15/202416:05GLOBERezolute Reports Third Quarter Fiscal 2024 Financial Results..
4/23/202408:00GLOBEPhase 2 RIZE Study Sub-Analyses to be Presented at the 2024..
3/11/202417:03EDGAR2Form 8-K - Current report
3/11/202410:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202407:30GLOBERezolute Reports Validation of the Potential Use of RZ358..
2/27/202408:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202417:00EDGAR2Form 8-K - Current report
2/21/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202417:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202416:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/13/202416:10EDGAR2Form 8-K - Current report
2/13/202416:05GLOBERezolute Reports Second Quarter Fiscal 2024 Results and..
1/29/202417:15EDGAR2Form 8-K - Current report
1/25/202412:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202412:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202408:00GLOBERezolute Expands Leadership Team with Appointment of Daron..
1/23/202408:00GLOBERezolute Receives Innovation Passport Designation from the..
12/14/202316:01EDGAR2Form 8-K - Current report
12/14/202308:00GLOBERezolute Initiates Phase 3 Clinical Study for RZ358 in..
12/13/202308:00GLOBERezolute Completes Enrollment of its Phase 2 Study in..
11/30/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
11/22/202317:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/22/202316:35EDGAR2Form 8-K - Current report
11/17/202308:00GLOBERezolute to Participate in BTIG’s 3rd Annual Ophthalmology..
11/15/202309:08EDGAR2Form S-3 - Registration statement under Securities Act of..
11/13/202316:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:13EDGAR2Form 8-K - Current report
11/13/202316:05GLOBERezolute Reports First Quarter Fiscal 2024 Results
10/18/202316:30EDGAR2Form 8-K - Current report
10/17/202308:00GLOBERezolute Receives Priority Medicines (PRIME) Eligibility..
10/13/202316:47EDGAR2Form 8-K - Current report
10/13/202316:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/11/202308:00GLOBERezolute Announces Further Evidence of RZ358’s Efficacy in..
9/14/202316:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
9/14/202316:10EDGAR2Form 8-K - Current report
9/14/202316:05GLOBERezolute Reports Full Year Fiscal 2023 Results and..
9/06/202307:00GLOBERezolute to Participate in Upcoming Investor Conferences in..
7/06/202311:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/27/202316:05GLOBERezolute to Initiate a Pivotal Phase 3 Study of RZ358 in..

Your Recent History

Delayed Upgrade Clock